<code id='6DB6392246'></code><style id='6DB6392246'></style>
    • <acronym id='6DB6392246'></acronym>
      <center id='6DB6392246'><center id='6DB6392246'><tfoot id='6DB6392246'></tfoot></center><abbr id='6DB6392246'><dir id='6DB6392246'><tfoot id='6DB6392246'></tfoot><noframes id='6DB6392246'>

    • <optgroup id='6DB6392246'><strike id='6DB6392246'><sup id='6DB6392246'></sup></strike><code id='6DB6392246'></code></optgroup>
        1. <b id='6DB6392246'><label id='6DB6392246'><select id='6DB6392246'><dt id='6DB6392246'><span id='6DB6392246'></span></dt></select></label></b><u id='6DB6392246'></u>
          <i id='6DB6392246'><strike id='6DB6392246'><tt id='6DB6392246'><pre id='6DB6392246'></pre></tt></strike></i>

          leisure time

          leisure time

          author:Wikipedia    Page View:83247
          Cathy McMorris Rodgers -- health policy coverage from STAT
          Rep. Cathy McMorris Rodgers announced her plans to leave Congress at the end of 2024. Anna Moneymaker/Getty Images

          WASHINGTON — Rep. Cathy McMorris Rodgers, the chair of a crucial House committee that handles health care issues, plans to leave Congress at the end of the year, she announced Thursday.

          It will be a major shakeup for a panel already ravaged by Republican retirements. Reps. Michael Burgess (R-Texas), Larry Bucshon (R-Ind.), Jeff Duncan (R-S.C.), Debbie Lesko (R-Ariz.), Greg Pence (R-Ind.) and Kelly Armstrong (R-N.D.) are all leaving at the end of this Congress, too.

          advertisement

          Under McMorris Rodgers, the panel led the way for House passage of a health care price transparency package that included the first major proposal to equalize payment between hospital outpatient departments and physician offices.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK
          JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

          InhonorofJPMWeek,you’rereadingaspecialeditionofourbiotechnewsletter,TheReadout.Tostayontopofthelates

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Stories you might have missed in 2023: health, science, medicine

          Oneofourfavoritestoriesfeaturedoneofourfavoriteillustrations.MikeReddyforSTATThere’sanoldstoryinjour